Kevin Tausend

Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.

Target Therapeutics, Inc. develops, manufactures and markets disposable and implantable medical devices. It provides medical devices used in minimally invasive procedures to treat vascular diseases and other diseases related to small vessels of the circulatory system. The company was founded by Anna Marie and John R. Daniels in 1985 and is headquartered in Fremont, CA.

EndoGastric Solutions, Inc. develops natural orifice surgical products and procedures to advance the treatment of gastrointestinal diseases. The firm offers EsophyX device and StomaphyX device. The company was founded by Stefan J. M. Kraemer, Clifton A. Alferness, Scott Jordan Wolf, James W. Fitzsimmons and John M. Adams in 2003 and is headquartered in Redmond City, WA.

Benvenue Medical, Inc. engages int the provision and development of invasive systems for spine repair. It offers Kiva an implant solution for vertebral augmentation and a departure from balloon kyphoplasty, Blazer-C a vertebral augmentation system that utilizes a unique cannulated curved wire offering mechanical channel creation, and Luna a interbody implant that is delivered through a minimally-invasive cannula to the disc space and expands in-situ. The company was founded by Laurent B. Schaller in 2004 and is headquartered in Santa Clara, CA.

Tibion Corp. designs and develops medical devices. It develops innovative equipment that helps individuals recover physical function lost due to disease, trauma or aging. The company was founded was founded by Kern Bhugra and Robert Horst in 2002 and is headquartered in Sunnyvale, CA.

Optivia Biotechnology, Inc. provides contract research organization offering drug transporter research services and solutions to biotechnology, pharmaceutical and academic organizations. It offers regulatory DDI studies, transporter screening, tranporter profiling, and custom development services. The firm's products include TransFlex Single Transporter Assay Plates,TransFlex Multi-Transporter Model Plates, and Certified Efflux Transporter Vesicles. The company was founded by Yong Huang, Pascal Druzgala and Peter G. Milner in 2007 and is headquartered in Santa Clara, CA.

CyberHeart, Inc. engages in the development of stereotactic radiosurgery for cardiovascular conditions. It also offers CyberHeart System a proprietary technology and medical software that enables the use of the same hardware to non-invasively treat cardiac arrhythmias. The company was founded by Thomas J. Fogarty and Roderick A. Young and is headquartered in Mountain View, CA.

Bacchus Vascular, Inc. manufactures and sells medical devices. It provides treatments for peripheral vascular diseases. The company was founded by Nellix Michael and Thomas J. Fogarthy in 1999 and is headquartered in Santa Clara, CA.

Vivant Medical, Inc. develops microwave ablation system. It offers treatment of benign and cancerous soft tissue tumors. The company was founded by Thomas J. Fogarty on October 39, 1998 and is headquartered in Mountain View, CA.

Novare Surgical Systems, Inc. manufactures and supplies surgical equipment. Its products include laparoscopic, surgical, electrosurgical instruments, surgical laser and clamps, skin markers and orthopedic appliances. The company was founded by Thomas J. Fogarty and Kerry Pope in 1999 and is headquartered in Cupertino, CA.

Wallace Enterprises, Inc. develops, manufactures and markets devices for treating peripheral vascular disease and nonvascular obstructions. The company was founded by Thomas J. Fogarty in 1997 and is headquartered in Nashville, TN.

Cianna Medical, Inc. manufactures and marketing equipment for the treatment of early-stage breast cancer in women. The firm’s products include SAVI, a breast brachytherapy applicator used for the delivery of radiation after lumpectomy surgery; and SAVI SCOUT, a surgical guidance system that uses real-time audible and visual indicators to give surgeons a precise way to target tissue during lumpectomy and excisional biopsy procedures. The company was founded in 2007 and is headquartered in Aliso Viejo, CA.

EMP Management LLC /CA/ (EMP Management) is an venture capital firm founded in 2007 by Allan W. May. The firm is headquartered in San Jose, California.

Ischemix, Inc. is a privately-held drug development company based in an undisclosed location. The American company focuses on developing its family of cytoprotective compounds for serious diseases and conditions, with the primary focus being the development of its lead compound, CMX-2043, for the treatment of TBI. Ischemix is working to advance cytoprotective therapies. The company was founded in 1999 by Victor Shashoua, and David DeWahl has been the CEO of the company since 2013.

Part of Abbott Laboratories, Abbott Vascular, Inc. is a company that manufactures cardiac and vascular care systems. The company is based in Abbott Park, IL.

Retrotope, Inc. operates as clinical-stage pharmaceutical company that develops drugs to treat degenerative diseases. It offers drugs and therapies to treat Parkinson’s, Alzheimer’s, mitochondrial myopathies and retinopathies diseases. The company was founded by Charles R. Cantor, Robert J. Molinari, and Mikhail S. Shchepinov in 2006 and is headquartered in Los Altos, CA.

Fogarty Institute for Innovation is a non-profit company that believes innovation is the key to medical advancement. The company is based in Mountain View, CA. The company strives to shape the future of human health through their work. The company was founded by Thomas J. Fogarty. Andrew Cleeland has been the CEO of the company since 2017.

Renexxion LLC is a gastrointestinal biopharmaceutical company. It develops naronapride. The company was founded by Peter G. Milner, Muralitharan Kengatharan , and Pascal J. Druzgala in 2014 and is headquartered in Menlo Park, CA.